Published in J Virol on June 18, 2008
Viral tricks to grid-lock the type I interferon system. Curr Opin Microbiol (2010) 2.17
The regulation of type I interferon production by paramyxoviruses. J Interferon Cytokine Res (2009) 1.27
The matrix protein of measles virus regulates viral RNA synthesis and assembly by interacting with the nucleocapsid protein. J Virol (2009) 1.24
Paramyxovirus disruption of interferon signal transduction: STATus report. J Interferon Cytokine Res (2009) 1.21
Protein kinase PKR mediates the apoptosis induction and growth restriction phenotypes of C protein-deficient measles virus. J Virol (2008) 1.18
Mechanisms of protein kinase PKR-mediated amplification of beta interferon induction by C protein-deficient measles virus. J Virol (2010) 1.18
Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol (2010) 1.18
Paramyxovirus V proteins interact with the RNA Helicase LGP2 to inhibit RIG-I-dependent interferon induction. J Virol (2012) 1.17
Measles virus V protein inhibits NLRP3 inflammasome-mediated interleukin-1β secretion. J Virol (2011) 1.06
Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus. J Virol (2012) 1.02
Measles virus C protein interferes with Beta interferon transcription in the nucleus. J Virol (2011) 1.01
Measles viruses possessing the polymerase protein genes of the Edmonston vaccine strain exhibit attenuated gene expression and growth in cultured cells and SLAM knock-in mice. J Virol (2008) 0.96
Wild-Type Measles Virus is Intrinsically Dual-Tropic. Front Microbiol (2012) 0.95
A recombinant measles virus unable to antagonize STAT1 function cannot control inflammation and is attenuated in rhesus monkeys. J Virol (2010) 0.94
Mitophagy enhances oncolytic measles virus replication by mitigating DDX58/RIG-I-like receptor signaling. J Virol (2014) 0.93
Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response. PLoS One (2012) 0.92
Sustained autophagy contributes to measles virus infectivity. PLoS Pathog (2013) 0.90
Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein. J Virol (2012) 0.89
Measles virus C protein impairs production of defective copyback double-stranded viral RNA and activation of protein kinase R. J Virol (2013) 0.89
Mumps virus Enders strain is sensitive to interferon (IFN) despite encoding a functional IFN antagonist. J Gen Virol (2009) 0.86
Cell tropism and pathogenesis of measles virus in monkeys. Front Microbiol (2012) 0.86
Human parainfluenza virus type 2 V protein inhibits TRAF6-mediated ubiquitination of IRF7 to prevent TLR7- and TLR9-dependent interferon induction. J Virol (2013) 0.86
Adaptation to cell culture induces functional differences in measles virus proteins. Virol J (2008) 0.84
Induction of dendritic cell production of type I and type III interferons by wild-type and vaccine strains of measles virus: role of defective interfering RNAs. J Virol (2013) 0.83
Measles virus nonstructural C protein modulates viral RNA polymerase activity by interacting with host protein SHCBP1. J Virol (2013) 0.83
Expression of the Sendai (murine parainfluenza) virus C protein alleviates restriction of measles virus growth in mouse cells. Proc Natl Acad Sci U S A (2011) 0.82
Antagonism of innate immunity by paramyxovirus accessory proteins. Viruses (2009) 0.81
Evolution and structural organization of the C proteins of paramyxovirinae. PLoS One (2014) 0.81
The measles virus phosphoprotein interacts with the linker domain of STAT1. Virology (2013) 0.81
Mechanisms underlying the inhibition of interferon signaling by viruses. Virulence (2014) 0.80
No evidence for an association between persistent measles virus infection and otosclerosis among patients with otosclerosis in Japan. J Clin Microbiol (2012) 0.79
A highly attenuated measles virus vaccine strain encodes a fully functional C protein. J Virol (2009) 0.79
Creation of a completely helper cell-dependent recombinant morbillivirus. J Gen Virol (2013) 0.78
N-terminally truncated C protein, CNDelta25, of human parainfluenza virus type 3 is a potent inhibitor of viral replication. Virology (2009) 0.77
A correlation of measles specific antibodies and the number of plasmacytoid dendritic cells is observed after measles vaccination in 9 month old infants. Hum Vaccin Immunother (2015) 0.75
Host-Pathogen Interactions in Measles Virus Replication and Anti-Viral Immunity. Viruses (2016) 0.75
Actin-Modulating Protein Cofilin Is Involved in the Formation of Measles Virus Ribonucleoprotein Complex at the Perinuclear Region. J Virol (2015) 0.75
Modulation of Host Immunity by the Human Metapneumovirus. Clin Microbiol Rev (2016) 0.75
The V protein of canine distemper virus is required for virus replication in human epithelial cells. PLoS One (2013) 0.75
Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 32.58
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature (2006) 22.65
CRM1 is an export receptor for leucine-rich nuclear export signals. Cell (1997) 18.60
WHO estimates of the causes of death in children. Lancet (2005) 18.33
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science (2006) 16.00
5'-Triphosphate RNA is the ligand for RIG-I. Science (2006) 15.78
pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res (1990) 12.75
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol (2008) 8.85
Viruses and interferon: a fight for supremacy. Nat Rev Immunol (2002) 7.92
The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A (2004) 7.51
A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A (1997) 6.86
Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol (2000) 6.22
SLAM (CDw150) is a cellular receptor for measles virus. Nature (2000) 6.07
Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol (2006) 4.88
The interferon response circuit: induction and suppression by pathogenic viruses. Virology (2006) 4.56
Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol (2003) 4.45
Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature (2007) 4.13
Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J Virol (1990) 3.60
Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides. Virology (1980) 3.53
Measles virus P gene codes for two proteins. J Virol (1985) 3.31
Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol (2001) 3.27
Recognition of viruses by innate immunity. Immunol Rev (2007) 3.23
Measles virus editing provides an additional cysteine-rich protein. Cell (1989) 3.22
Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J Virol (1999) 2.99
Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis. Mol Cell Biol (1986) 2.72
Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J Gen Virol (1979) 2.69
mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology (2006) 2.64
STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J Virol (2003) 2.54
Recovery of pathogenic measles virus from cloned cDNA. J Virol (2000) 2.19
Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS One (2007) 2.18
The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis. Virology (1992) 2.17
Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses. Microbes Infect (2002) 2.17
SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol (2002) 2.09
Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. Virology (1997) 2.01
The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology (1996) 1.95
The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion. J Virol (1996) 1.94
Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. Virology (2006) 1.80
Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett (2003) 1.74
Nonhuman primate models of measles. Lab Anim Sci (1996) 1.65
Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J Virol (1998) 1.63
Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J Virol (1998) 1.62
Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity. J Virol (2005) 1.61
V and C proteins of measles virus function as virulence factors in vivo. Virology (2000) 1.61
Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J Gen Virol (2004) 1.59
Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates. Virology (1999) 1.54
Modulating the function of the measles virus RNA-dependent RNA polymerase by insertion of green fluorescent protein into the open reading frame. J Virol (2002) 1.51
The C protein of measles virus inhibits the type I interferon response. Virology (2003) 1.47
The role of simian virus 5 V protein on viral RNA synthesis. Virology (2005) 1.46
Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-alpha/beta signaling. Virology (2007) 1.44
Dynamics of viral RNA synthesis during measles virus infection. J Virol (2005) 1.44
All four Sendai Virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation. Virology (2002) 1.41
The Sendai virus C protein binds the L polymerase protein to inhibit viral RNA synthesis. Virology (1997) 1.41
Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. J Virol (2001) 1.39
Triggering antiviral response by RIG-I-related RNA helicases. Biochimie (2007) 1.37
Versatility of the accessory C proteins of Sendai virus: contribution to virus assembly as an additional role. J Virol (2000) 1.33
Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus. J Virol (2006) 1.28
Mutations in the measles virus C protein that up regulate viral RNA synthesis. Virology (2001) 1.27
Measles virus synthesizes both leaderless and leader-containing polyadenylated RNAs in vivo. J Virol (1989) 1.22
Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor function. J Virol (2004) 1.21
Stringent requirement for the C protein of wild-type measles virus for growth both in vitro and in macaques. J Virol (2005) 1.17
Efficient rescue of measles virus from cloned cDNA using SLAM-expressing Chinese hamster ovary cells. Virus Res (2005) 1.10
Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice. J Virol (2007) 1.09
Protein interactions entered into by the measles virus P, V, and C proteins. Virus Res (1995) 1.08
Paramyxovirus-induced shutoff of host and viral protein synthesis: role of the P and V proteins in limiting PKR activation. J Virol (2007) 1.08
Inhibition of STAT 1 phosphorylation by human parainfluenza virus type 3 C protein. J Virol (2005) 1.04
Identification of naturally occurring amino acid variations that affect the ability of the measles virus C protein to regulate genome replication and transcription. Virology (2005) 1.02
The human parainfluenza virus type 3 (HPIV 3) C protein inhibits viral transcription. Virus Res (2004) 0.96
Rescue system for measles virus from cloned cDNA driven by vaccinia virus Lister vaccine strain. J Virol Methods (2006) 0.96
Isolation and characterization of a Chinese hamster ovary mutant cell line with altered sensitivity to vaccinia virus killing. J Virol (1996) 0.95
Growth sensitivity of a recombinant simian virus 5 P/V mutant to type I interferon differs between tumor cell lines and normal primary cells. Virology (2005) 0.94
The phosphoprotein of attenuated measles AIK-C vaccine strain contributes to its temperature-sensitive phenotype. Vaccine (2005) 0.87
The C protein of wild-type measles virus has the ability to shuttle between the nucleus and the cytoplasm. Microbes Infect (2007) 0.85
Inhibition of measles virus minireplicon-encoded reporter gene expression by V protein. Virology (2006) 0.84
Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc Natl Acad Sci U S A (2007) 2.56
Mitofusin 2 inhibits mitochondrial antiviral signaling. Sci Signal (2009) 2.25
Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog (2007) 2.09
SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol (2002) 2.09
Proteolytic activation of the 1918 influenza virus hemagglutinin. J Virol (2009) 2.05
Measles virus: cellular receptors, tropism and pathogenesis. J Gen Virol (2006) 2.04
Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis (2011) 2.03
Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat Struct Mol Biol (2011) 1.85
Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes. Dev Cell (2003) 1.77
Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett (2003) 1.74
Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer. Breast Cancer Res Treat (2002) 1.69
SAP regulation of follicular helper CD4 T cell development and humoral immunity is independent of SLAM and Fyn kinase. J Immunol (2007) 1.68
Efficient isolation of wild strains of canine distemper virus in Vero cells expressing canine SLAM (CD150) and their adaptability to marmoset B95a cells. J Virol (2003) 1.66
Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in T(H)2 cytokine regulation. Immunity (2004) 1.63
Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J Virol (2008) 1.62
Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity. J Virol (2005) 1.61
Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J Gen Virol (2004) 1.59
Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly. J Virol (2005) 1.58
Activation of PI3K/Akt signaling and hormone resistance in breast cancer. Breast Cancer (2006) 1.57
Cooperation between different RNA virus genomes produces a new phenotype. Nat Commun (2012) 1.53
Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling. Sci Signal (2011) 1.50
Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol (2010) 1.44
A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors. Int J Clin Oncol (2005) 1.42
A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism. J Virol (2007) 1.39
Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2. J Virol (2008) 1.37
Influenza B virus BM2 protein is an oligomeric integral membrane protein expressed at the cell surface. Virology (2003) 1.34
Nectin4 is an epithelial cell receptor for canine distemper virus and involved in neurovirulence. J Virol (2012) 1.34
Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer. Breast Cancer (2009) 1.30
Dynamic interaction of the measles virus hemagglutinin with its receptor signaling lymphocytic activation molecule (SLAM, CD150). J Biol Chem (2008) 1.29
Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains. Biochem Biophys Res Commun (2003) 1.28
Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus. J Virol (2006) 1.28
Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2. Breast Cancer (2013) 1.26
Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival. Breast Cancer Res Treat (2007) 1.25
The matrix protein of measles virus regulates viral RNA synthesis and assembly by interacting with the nucleocapsid protein. J Virol (2009) 1.24
Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population. Cancer (2010) 1.23
Encephalomyocarditis virus viroporin 2B activates NLRP3 inflammasome. PLoS Pathog (2012) 1.22
Triggering the measles virus membrane fusion machinery. Proc Natl Acad Sci U S A (2012) 1.20
Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer. Clin Cancer Res (2002) 1.20
Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently. J Virol (2006) 1.19
Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol (2010) 1.18
Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer (2002) 1.18
Stringent requirement for the C protein of wild-type measles virus for growth both in vitro and in macaques. J Virol (2005) 1.17
The association between Akt activation and resistance to hormone therapy in metastatic breast cancer. Eur J Cancer (2006) 1.16
Lethal canine distemper virus outbreak in cynomolgus monkeys in Japan in 2008. J Virol (2012) 1.14
The 3' enhancer CNS2 is a critical regulator of interleukin-4-mediated humoral immunity in follicular helper T cells. Immunity (2012) 1.14
Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion. J Virol (2007) 1.13
Ruptured distal anterior inferior cerebellar artery aneurysm following stereotactic irradiation for vestibular schwannoma: case report. Neurol Med Chir (Tokyo) (2009) 1.12
Contributions of matrix and large protein genes of the measles virus edmonston strain to growth in cultured cells as revealed by recombinant viruses. J Virol (2005) 1.12
Efficient rescue of measles virus from cloned cDNA using SLAM-expressing Chinese hamster ovary cells. Virus Res (2005) 1.10
Phyllodes tumor of the breast: correlation between MR findings and histologic grade. Radiology (2006) 1.08
Measles virus V protein inhibits NLRP3 inflammasome-mediated interleukin-1β secretion. J Virol (2011) 1.06
Measles virus hemagglutinin: structural insights into cell entry and measles vaccine. Front Microbiol (2011) 1.06
The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses. J Virol (2014) 1.05
Absence of tumour necrosis factor facilitates primary and recurrent herpes simplex virus-1 infections. J Gen Virol (2004) 1.05
Wild-type measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM(CD150)-independent mechanism. Virus Res (2003) 1.05
Genetic characterization of measles vaccine strains. J Infect Dis (2011) 1.04
Histidine at position 61 and its adjacent amino acid residues are critical for the ability of SLAM (CD150) to act as a cellular receptor for measles virus. J Gen Virol (2003) 1.02
Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection. J Virol (2006) 1.02
Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancer. Surgery (2003) 1.02
Epithelial-mesenchymal transition abolishes the susceptibility of polarized epithelial cell lines to measles virus. J Biol Chem (2010) 1.01
The morbillivirus receptor SLAM (CD150). Microbiol Immunol (2002) 0.99
Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection. Proc Natl Acad Sci U S A (2013) 0.99
Composite Y-graft for syphilitic ostial stenosis in left main coronary artery. Asian Cardiovasc Thorac Ann (2007) 0.98
Restriction of measles virus RNA synthesis by a mouse host cell line: trans-complementation by polymerase components or a human cellular factor(s). J Virol (2002) 0.98
Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells. Eur J Cancer (2010) 0.98
Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients. Int J Oncol (2005) 0.98
Generation of measles virus with a segmented RNA genome. J Virol (2006) 0.97
F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner. J Clin Invest (2015) 0.97
Prognostic value of c-erbB2 expression in breast cancer. J Surg Oncol (2002) 0.97
Concurrent overexpression of Ets-1 and c-Met correlates with a phenotype of high cellular motility in human esophageal cancer. Int J Cancer (2002) 0.97